» Authors » Karl Egerer

Karl Egerer

Explore the profile of Karl Egerer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 725
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Loock C, Egerer K, Feist E, Burmester G
RMD Open . 2017 Aug; 3(1):e000409. PMID: 28848653
Introduction: Visual evaluation of indirect immunofluorescence (IIF) on human epithelial-2 cells is the routine method for screening for antinuclear antibodies (ANA) in connective tissue diseases. Since visual IIF is time-consuming...
2.
Lindenberg L, Spengler L, Bang H, Dorner T, Maslyanskiy A, Lapin S, et al.
Arthritis Res Ther . 2015 Aug; 17:206. PMID: 26268352
Introduction: Antibodies against mutated citrullinated vimentin (AMCV) represent a useful diagnostic marker with correlation to disease activity in patients with rheumatoid arthritis (RA). Since seropositivity for citrullinated autoantibodies was predictive...
3.
Derganova O, Martinez-Gamboa L, Egerer K, Bang H, Fredenhagen G, Roggenbuck D, et al.
Clin Exp Rheumatol . 2014 Sep; 32(5):622-9. PMID: 25189876
Objectives: Antibodies against citrullinated antigens (ACPA) represent one rheumatoid arthritis (RA) classification criteria. Recently, mutated and citrullinated vimentin (MCV), containing approx. 45 potentially citrullinated sites, was characterised as another modified...
4.
Martinez-Gamboa L, Lesemann K, Kuckelkorn U, Scheffler S, Ghannam K, Hahne M, et al.
J Rheumatol . 2013 Mar; 40(5):663-73. PMID: 23504381
Objective: Dysregulation of proteasome subunit β1i expression has been shown in total blood mononuclear cells (PBMC) from patients with primary Sjögren syndrome (pSS), a B cell-driven systemic autoimmune disorder. Methods:...
5.
Florcken A, Kopp J, van Lessen A, Movassaghi K, Takvorian A, Johrens K, et al.
Hum Vaccin Immunother . 2013 Mar; 9(6):1217-27. PMID: 23458999
Multi-kinase inhibitors have been established for the treatment of advanced renal cell cancer, but long-term results are still disappointing and immunotherapeutic approaches remain an interesting experimental option particularly in patients...
6.
Roggenbuck D, Egerer K, von Landenberg P, Hiemann R, Feist E, Burmester G, et al.
Autoimmun Rev . 2012 Sep; 11(11):821-6. PMID: 23006529
Detection of anti-phospholipid (aPL) antibodies for state-of-the art diagnosis of antiphospholipid syndrome(APS) still remains a laboratory challenge due to the great diversity of aPL antibodies and their relevance with regard...
7.
Detert J, Bastian H, Listing J, Weiss A, Wassenberg S, Liebhaber A, et al.
Ann Rheum Dis . 2012 Jun; 72(6):844-50. PMID: 22739990
Objective: To investigate the long-term effects of induction therapy with adalimumab (ADA) plus methotrexate (MTX) in comparison with placebo (PBO) plus MTX in DMARD-naïve patients with active early rheumatoid arthritis...
8.
Roggenbuck D, Egerer K, Feist E, Burmester G, Dorner T
Arthritis Rheum . 2012 May; 64(8):2807-8. PMID: 22614803
No abstract available.
9.
Frisch E, Kaup M, Egerer K, Weimann A, Tauber R, Berger M, et al.
Electrophoresis . 2011 Dec; 32(24):3510-5. PMID: 22180205
High-mannose and hybrid-type N-glycans are present in human serum glycoproteins in low abundance but have recently been described to play an important role in immune responses. It is therefore important...
10.
Engler J, Undeutsch R, Kloke L, Rosenberger S, Backhaus M, Schneider U, et al.
Ann Rheum Dis . 2011 Sep; 70(12):2176-83. PMID: 21926188
Objective: Autoreactive CD4 T cells specific for nuclear peptide antigens play an important role in tolerance breakdown during the course of systemic lupus erythematosus (SLE). However, reliable detection of these...